Altamira Therapeutics Ltd. (CYTO)
NASDAQ: CYTO · IEX Real-Time Price · USD
1.640
+0.020 (1.23%)
At close: May 3, 2024, 3:59 PM
1.580
-0.060 (-3.66%)
After-hours: May 3, 2024, 7:48 PM EDT
Altamira Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
3.67M USD
Revenue Chart
* The company reports in CHF currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 0 | - | - |
Dec 31, 2012 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
China Jo-Jo Drugstores | 154.66M |
Applied DNA Sciences | 9.00M |
ReShape Lifesciences | 8.68M |
Aethlon Medical | 574.25K |
Finch Therapeutics Group | 107.00K |
CYTO News
- 2 days ago - Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation - GlobeNewsWire
- 9 days ago - Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal - GlobeNewsWire
- 4 weeks ago - Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024 - GlobeNewsWire
- 5 weeks ago - Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines - GlobeNewsWire
- 3 months ago - Altamira Therapeutics' Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal - GlobeNewsWire
- 3 months ago - Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment - GlobeNewsWire
- 4 months ago - Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit - GlobeNewsWire
- 4 months ago - Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire